Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
24
PPTDF Quote, Financials, Valuation and Earnings
Last price:
$11.50
Seasonality move
:
-3.15%
Day range:
$11.50 - $11.50
52-week range:
$10.82 - $18.00
Dividend yield:
0%
P/E ratio:
14.28x
P/S ratio:
4.93x
P/B ratio:
4.07x
Volume:
--
Avg. volume:
335
1-year change:
-19.58%
Market cap:
$1.5B
Revenue:
$308.5M
EPS (TTM):
$0.81
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, PeptiDream has -- downside to fair value with a price target of -- per share.
PPTDF vs. S&P 500
-
Over the past 5 trading days, PeptiDream has underperformed the S&P 500 by -12.8% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
PeptiDream does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
PeptiDream revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter PeptiDream reported revenues of $27.8M.
Earnings Growth
-
PeptiDream has grown year-over-year earnings for 1 quarter straight. In the most recent quarter PeptiDream reported earnings per share of -$0.05.
Enterprise value:
1.4B
EV / Invested capital:
--
Price / LTM sales:
4.93x
EV / EBIT:
9.24x
EV / Revenue:
4.56x
PEG ratio (5yr expected):
0.44x
EV / Free cash flow:
-19.29x
Price / Operating cash flow:
13.50x
Enterprise value / EBITDA:
8.38x
Gross Profit (TTM):
$222.5M
Return On Assets:
20.65%
Net Income Margin (TTM):
34.53%
Return On Equity:
34.1%
Return On Invested Capital:
23.58%
Operating Margin:
-32.3%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $228.8M | $193.6M | $302.7M | $28.5M | $27.8M | |
| Gross Profit | $147.1M | $114.5M | $222.5M | $10M | $9.6M | |
| Operating Income | $69.8M | $41.1M | $148.9M | -$7.4M | -$9M | |
| EBITDA | $87.1M | $57.6M | $164.8M | -$2.7M | -$4.5M | |
| Diluted EPS | $0.44 | $0.13 | $0.81 | -$0.04 | -$0.05 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $120.6M | $146.5M | $159.1M | $233.7M | $300.4M | |
| Total Assets | $219M | $426.9M | $448.6M | $460.1M | $539.6M | |
| Current Liabilities | $18.7M | $50.6M | $58.1M | $66.7M | $58.7M | |
| Total Liabilities | $21.8M | $224.7M | $209.9M | $195.9M | $173.4M | |
| Total Equity | $197.2M | $202.2M | $238.7M | $264.2M | $366.1M | |
| Total Debt | -- | $181.8M | $150.1M | $142.5M | $126.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $58M | $17M | -$56.6M | -$13M | -$64.4M | |
| Cash From Investing | -$8.5M | $82.2M | $54M | $70M | -$6.9M | |
| Cash From Financing | -$40.2M | $5.4M | $1.5M | -$5.1M | -$11.3M | |
| Free Cash Flow | $28.4M | $6.4M | -$71.6M | -$16.6M | -$69.4M | |
PPTDF
Sector
Market Cap
$1.5B
$34.4M
Price % of 52-Week High
63.89%
48.88%
Dividend Yield
0%
0%
Shareholder Yield
0.34%
-1.01%
1-Year Price Total Return
-19.58%
-37.36%
Beta (5-Year)
0.523
0.614
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$12.15
200-day SMA
Sell
Level
$15.98
Bollinger Bands (100)
Sell
Level
12.17 - 17.09
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$12.25
Relative Strength Index (RSI14)
Sell
Level
31.62
ADX Line
Sell
Level
28.33
Williams %R
Buy
Level
-91.3043
50-day SMA
Sell
Level
$12.91
MACD (12, 26)
Buy
Level
2.84
25-day Aroon Oscillator
Sell
Level
-8
On Balance Volume
Sell
Level
-207
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (8.6191)
Buy
CA Score
(Annual)
Level (1.3924)
Buy
Beneish M-Score
(Annual)
Level (-3.6748)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-2.433)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
PeptiDream Inc is a biopharmaceutical company, engaged in the research and development of new pharmaceutical candidates. It discovers constrained peptides, small molecules, and peptide-drug conjugate therapeutics using its Peptide Discovery Platform System. The company aspires to be a leader in drug discovery and development to address unmet medical needs and improve the quality of life of patients worldwide.
Stock Forecast FAQ
In the current month, PPTDF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PPTDF average analyst price target in the past 3 months is --.
-
Where Will PeptiDream Stock Be In 1 Year?
According to analysts, the consensus estimate is that PeptiDream share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About PeptiDream?
Analysts are divided on their view about PeptiDream share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that PeptiDream is a Sell and believe this share price will rise from its current level to --.
-
What Is PeptiDream's Price Target?
The price target for PeptiDream over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is PPTDF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for PeptiDream is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of PPTDF?
You can purchase shares of PeptiDream via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase PeptiDream shares.
-
What Is The PeptiDream Share Price Today?
PeptiDream was last trading at $11.50 per share. This represents the most recent stock quote for PeptiDream. Yesterday, PeptiDream closed at $11.50 per share.
-
How To Buy PeptiDream Stock Online?
In order to purchase PeptiDream stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
